A-share innovative drug sector saw a short-term surge, with Baihua Pharmaceutical hitting the daily limit for the seventh consecutive day, while Wanbang Pharmaceutical, Hongbo Pharmaceutical, Longshen Rongfa, Yuhang Pharmaceutical, Harbin Pharmaceutical Group, and Boji Pharmaceutical followed suit.